History
  • No items yet
midpage
Synergy Advanced Pharmaceuticals, Inc. v. Capebio, LLC
2011 U.S. Dist. LEXIS 56285
S.D.N.Y.
2011
Read the full case

Background

  • Synergy sues CapeBio, CombiMab, and Lindell in New York state court for breach of the 2007 Agreement and related conduct.
  • CapeBio allegedly assigned inventions to Synergy and Lindell allegedly formed CombiMab as an alter ego and shell entity.
  • The 2007 Agreement included an assignment of inventions to Synergy, and confidentiality, non-disclosure, and non-compete provisions surviving termination.
  • Synergy previously filed a state court action in 2009; that action was discontinued without prejudice after Lindell swore no breach.
  • Synergy refiled in 2009 (amended), asserting Lindell's related conduct through CapeBio and CombiMab, seeking, among other relief, assignment of patents.
  • Defendants removed to federal court based on diversity; discovery occurred; Synergy later moved to remand upon discovering no diversity.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the action arises under federal patent law Synergy argues federal patent law governs certain claims. CapeBio/CombiMab contend the claim hinges on patent law. The suit does not arise under patent law.
Whether CapBio and CombiMab are dispensable parties to preserve diversity Synergy argues dismissal would prejudice it and disrupt the case. Defendants rely on the Stipulation to equate Lindell's actions with the corporations. CapeBio and CombiMab may be dismissed to create diversity jurisdiction.
Whether removal was improper due to lack of diversity and fraud Synergy alleges fraudulent removal by omission of Delaware citizenship. Defendants contend removal was proper and seek alternative jurisdiction under patents. Removal was improper; dismissal of nondiverse parties cures jurisdiction.

Key Cases Cited

  • Christianson v. Colt Indus. Operating Corp., 486 U.S. 800 (U.S. 1988) (well-pleaded complaint must establish a federal patent-law basis)
  • Franchise Tax Bd. of the State of Cal. v. Construction Laborers Vacation Trust for S. Cal., 463 U.S. 1 (U.S. 1983) (test for arising under jurisdiction and federal question jurisdiction)
  • AT&T v. Integrated Network Corp., 972 F.2d 1321 (Fed. Cir. 1992) (conception of inventions may be broad; not all contract-language triggers patent jurisdiction)
  • HIF Bio, Inc. v. Yung Shin Pharm. Indus. Co., Ltd., 600 F.3d 1347 (Fed. Cir. 2010) (patent-law issues must be essential to the claim to confer jurisdiction)
  • Airlines Reporting Corp. v. S and N Travel, Inc., 58 F.3d 857 (2d Cir. 1995) (assignment/diversity considerations constrain federal jurisdiction)
  • Simpson v. Providence Washington Insurance Group, 608 F.2d 1171 (9th Cir. 1979) (reverse assignment to manufacture diversity analyzed; unusual fact pattern)
  • Kramer v. Caribbean Mills, Inc., 394 U.S. 823 (U.S. 1969) (diversity and jurisdictional limitations on fabricated party status)
Read the full case

Case Details

Case Name: Synergy Advanced Pharmaceuticals, Inc. v. Capebio, LLC
Court Name: District Court, S.D. New York
Date Published: May 25, 2011
Citation: 2011 U.S. Dist. LEXIS 56285
Docket Number: 10 Civ. 1736 (SAS)
Court Abbreviation: S.D.N.Y.